|
PAPERS,
ABSTRACTS,
CASE REPORTS,
LECTURE SLIDES
BY DR. BOB
|
All
articles,
case reports, and slides from lectures are available in Adobe Acrobat
(PDF) format.

|
|
PAPERS
BY DR. BOB
(& by Dr. Turner and/or others as
specified)
|
New!
PSA vs. CTC
by Jeffrey Turner MD (Prostate Cancer
Communication 27 (4): 7-9,
12/2011)
New!
Compassionate
Oncology's
Latest Three-Pronged Approach
Patient
Case Studies -
presented by
Jeffrey Turner MD & Bob Leibowitz MD at the Prostate
Forum of OC
Lecture on June 23, 2011, Fullerton CA
New!
Primary Triple Androgen
Blockade® (TAB) followed by Finasteride
Maintenance® (FM) for clinically localized prostate cancer (CL-PC):
Ten-year follow-up
coauthored
with Nathan Roundy
and Jeffrey
Turner
(Journal
of Clinical
Oncology, May 2011)
Testosterone Replacement in Prostate Cancer Survivors
with Hypogonadal Symptoms
coauthored with Tanya Dorff,
Steven
Tucker, James Symanowski
and
Nicholas Vogelzang
(British
Journal of Urology International,
May 2010; also published
early online 11/2009)
Dr. Bob's (Not So)
Secret Recipe for Treating Metastatic, Advanced Or Recurrent Prostate
Cancer (11/2008)
New!
Debunking an Old
Myth: Testosterone Replacement is Not Adding Fuel to the Fire in Men
with Prostate Cancer
by Jeffrey Turner MD (Prostate Cancer
Communication, 26 (4): 6-8,
12/2010)
New!
Degarelix, no more AGONIZING
by Jeffrey Turner MD (Prostate Cancer
Communication 26 (3): 13-16, 9/2010)
Taxotere Plus Avastin:
Antiangiogenic Proof of Principle
(4/2008)
AntiangiogenicCocktail (AAC) (8/2008),
formerly "LEUKINE (GM-CSF) and REVLIMID, the Second Generation
THALIDOMIDE Product" (updated
2/4/2008; originally written 09/2006)
Hormone Refractory Prostate Cancer (08/2004)
Treatment of
Localized Prostate Cancer With Intermittent Triple Androgen Blockade: Preliminary
Results in 110
Consecutive Patients (2001)
Hormone Blockade as the Sole Treatment of Clinical
Stages T1-T3 Prostate Cancer: Experience in 100 Patients (2000
ASCO Annual Meeting abstract)
Low-Dose Single Agent Weekly Docetaxel
(Taxotere) is Effective and Well Tolerated
in Elderly Men with
Prostate Cancer (2001 ASCO Annual Meeting
abstract)
- co-authored with M. Scholz,
B. Guess, F. Barrios, & S. Strum
Intermittent
Hormone Blockade for Localized Prostate Cancer (2001 ASCO Annual
Meeting abstract)
- co-authored with S. Tucker
Five-year Follow-up of Intermittent Triple Androgen
Blockade (TAB) for Clinically Localized Prostate Cancer (PC):
Prognostic Features and Preliminary Patterns of Failure
(2002 ASCO Annual Meeting abstract) -
co-authored with S. Tucker
At What PSA Level
Should Cycle Two of Hormone Blockade (HB) Commence in Men who Refuse
Local Treatment
for
Prostate Cancer (CaP) and are Treated with
Intermittent Androgen Blockade (IAB)?
(2002 ASCO Annual Meeting abstract) -
co-authored with S. Tucker
Low and Intermediate Risk Early Prostate Cancer (PC)
Managed with Triple Androgen Blockade (TAB) (2003 ASCO Annual
Meeting abstract) - co-authored with S. Tucker
Primary Triple Androgen Blockade (TAB) Followed by Finasteride Maintenance (FM) for Clinically Localized Prostate Cancer
(CL-PC): Long Term Follow-up
and Quality of Life (QOL)
(2005 ASCO Prostate Cancer Symposium
abstract) - co-authored with S. Tucker & J.N.
Roundy
Primary
Intermittent Chemo-Hormonal Therapy (CHT) for High Risk Locally
Advanced (LAPC) or
Metastatic
Prostate Cancer (MPC): Preliminary Results and Quality of Life (QOL)
(2005 ASCO Annual Meeting abstract) -
co-authored with S. Tucker
Triple Hormone Blockade® Update: The Demise of the
(Fool's) Gold Standard; The Rise of the "Platinum
and Diamond Standard”; Peer Recognition from the
Multidisciplinary Prostate Cancer Conference,
Orlando, Florida, February 2005, and the First International Conference
on IAB, London, England,
March 2005 (last updated 6/12/2008;
originally written 02/2006)
High-Dose Testosterone & Prostate Cancer : Wait
until you read this update, September 1, 2009
(9/1/2009)
Also see:
"High-Dose Testosterone Replacement Therapy and
Prostate Cancer"
"TRT Case
Reports: High Dose Testosterone Replacement Therapy (TRT) and
Prostate Cancer (CaP)"
TRT Case
Reports: High-Dose Testosterone Replacement Therapy (TRT) and Prostate
Cancer (CaP)
(updated 05/2009)
Also see:
"High-Dose Testosterone & Prostate Cancer : Wait
until you read this update, September 1, 2009"
"High-Dose Testosterone Replacement Therapy and
Prostate Cancer "
High-Dose Testosterone
Replacement Therapy and Prostate Cancer (11/2006),
Also see:
"High-Dose Testosterone & Prostate Cancer : Wait
until you read this update, September 1, 2009"
"TRT Case
Reports: High Dose Testosterone Replacement Therapy (TRT) and
Prostate Cancer (CaP)"
Proscar Greetings On Father's Day: 2008 Update(last
updated 6/25/08; originally written 06/1997)
I Am The Only One You
Are Afraid To Believe (01/1999)
Hormone Blockade;
Continuous, Intermittent, or ? formerly, "Dr. Bob's Approach,"
(03/06)
Potpourri of Prostate
Pearls and Insights (2007)
Statin Drugs and
Advanced Risk of Prostate Cancer (01/2007)
Testosterone Levels And Prostate Cancer -- The Higher,
The Better? (01/2003)
High-Dose Testosterone Replacement Therapy
(06/2004)
Testosterone
ASCO Abstract (Phase I trial of exogenous testosterone (T) for the
treatment of castrate metastatic
prostate cancer (PC) – Morris MJ et. al. (6/2004)),
Discussion by Robert L. Leibowitz, MD
05/2004
The Emperor's New Clothes or "The Platinum And Diamond
Standard" (04/2004),
Intermittent Androgen Blockade (Formerly "The Future
Is Now!!" - Part II) (04/2004),
Prostate "Pearls" (04/2004)
The Will Rogers
Phenomenon (04/2004)
Early Hormonal
Therapy Works Ridiculously Well (10/2003)
Celebrex, and
Anti-Cancer Activity (02/2007)
"PCAAC" Prostate Cancer Antiangiogenic
Cocktail (09/2002)
"The Facts, Doc, Just
The Facts" (04/2004)
Dawning Of The Age Of Angiogenesis (04/2004)
The Capitulation Of
Radiation Therapy Has Begun (04/2004)
Angiostatin And Why Local
Therapy Fails To Cure So Many Men (Formerly "The Transitional Zone Era")
(04/2004)
Hormone Blockade Versus Radical Local Therapies - And
The Winner Is.... (11/2002)
Soy and Prostate Cancer (10/2007)
Bisphosphonates and
Osteonecrosis of the Maxilla and/or Mandible (Jaw Bones)
(10/2005)
Aredia
Monotherapy to Control Metastatic,
Hormone Refractory Prostate Cancer for more than Six Years (11/2006)
The Risk of
Thrombosis (Blood Clots) with the use of Thalidomide and/or Revlimid (02/2007)
Interferon
and Anti-angiogenesis (6/2007)
Celebrex,
a Cox-2 Inhibtor: Off Label Use for
Treating Prostate and Other Cancers (12/2006)
December 2001 National Cancer Institute Article
(Treatment Options) (01/2002)
Dr.
Bob's Recommended Vitamin List (10/2005)
Shingles; Vaccine
and Post Shingles Pain (04/2009)
|
|
SLIDE
PRESENTATIONS
FROM LECTURES
GIVEN BY DR. BOB

|
All
presentations are available on DVD. For more information click here.
Dr. Bob's
Three-Pronged Approach for
Treating
High Risk Disease
and
Associated PC Pearls of Wisdom (2009)
Robert L. Leibowitz MD
Presentation sponored by the Wellness
Community, Westlake Village, CA
Conquering/Controlling/Taming
Advanced Prostate Cancer
and
|